Skip to main content

Articles

Page 13 of 17

  1. Development of tracers for imaging with positron emission tomography (PET) is often a time-consuming process associated with considerable attrition. In an effort to simplify this process, we herein propose a m...

    Authors: Markus Fridén, Marie Wennerberg, Madeleine Antonsson, Maria Sandberg-Ställ, Lars Farde and Magnus Schou

    Citation: EJNMMI Research 2014 4:50

    Content type: Original research

    Published on:

  2. Prostate cancer is a leading cause of death in the male population of the western world. Human kallikrein-related peptidase 2 (hK2) is abundantly expressed in malignant prostatic tissue, and its gene, KLK2, is re...

    Authors: Oskar Vilhelmsson Timmermand, David Ulmert, Susan Evans-Axelsson, Kim Pettersson, Anders Bjartell, Hans Lilja, Sven-Erik Strand and Thuy A Tran

    Citation: EJNMMI Research 2014 4:51

    Content type: Original research

    Published on:

  3. 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography (18F-FDG-PET) is applied in the clinic for infection assessment and is under consideration for investigating the inflammatory/immune response in lympho...

    Authors: Svetlana Chefer, Richard C Reba, Christopher Z Leyson, Jurgen Seidel, Reed F Johnson, Joseph E Blaney, Peter B Jahrling and Julie Dyall

    Citation: EJNMMI Research 2014 4:49

    Content type: Preliminary research

    Published on:

  4. Selective arterial radioembolisation of liver tumours has increased, because of encouraging efficacy reports; however, therapeutic parameters used in external beam therapy are not applicable for understanding ...

    Authors: Jonas Högberg, Magnus Rizell, Ragnar Hultborn, Johanna Svensson, Olof Henrikson, Johan Mölne, Peter Gjertsson and Peter Bernhardt

    Citation: EJNMMI Research 2014 4:48

    Content type: Original research

    Published on:

  5. Peptide receptor radionuclide therapy (PRRT) is an effective form of treatment for patients with metastatic neuroendocrine tumors (NETs). However, delivering sufficient radiation dose to the tumor to result in...

    Authors: David L Bushnell, Mark T. Madsen, Thomas O'cdorisio, Yusuf Menda, Saima Muzahir, Randi Ryan and M. Sue O'dorisio

    Citation: EJNMMI Research 2014 4:38

    Content type: Original research

    Published on:

  6. The multitargeting tyrosine kinase inhibitor (TKI) sunitinib is currently the first-line drug therapy for metastasizing renal cell carcinoma (RCC). TKIs have profound effects on tumor angiogenesis, leading to ...

    Authors: David W Chapman, Hans-Sonke Jans, Ivy Ma, John R Mercer, Leonard I Wiebe, Melinda Wuest and Ronald B Moore

    Citation: EJNMMI Research 2014 4:27

    Content type: Original research

    Published on:

  7. Glioblastoma, the most frequent and aggressive of all astrocytomas, presents a clear predominance in male humans, but the assessment of sexual differences in its tumourigenesis and growth has received little a...

    Authors: Rocío Pérez-Carro, Omar Cauli and Pilar López-Larrubia

    Citation: EJNMMI Research 2014 4:44

    Content type: Original research

    Published on:

  8. Inhibition of mitogen-activated protein kinase (MEK, also known as MAPK2, MAPKK), a key molecule of the Ras/MAPK (mitogen-activated protein kinase) pathway, has shown promising effects on B-raf-mutated and some R...

    Authors: Tetyana Tegnebratt, Elisabeth Ruge, Sabine Bader, Nobuya Ishii, Satoshi Aida, Yasushi Yoshimura, Chia-Huey Ooi, Li Lu, Nicholas Mitsios, Valerie Meresse, Jan Mulder, Michael Pawlak, Miro Venturi, Jean Tessier and Sharon Stone-Elander

    Citation: EJNMMI Research 2014 4:34

    Content type: Original research

    Published on:

  9. Targeted radionuclide therapy with high-energy beta-emitters is generally considered suboptimal to cure small tumours (<300 mg). Tumour targeting of the CCK2 receptor-binding minigastrin analogue PP-F11 was de...

    Authors: Mark W. Konijnenberg, Wout A. P. Breeman, Erik de Blois, Ho Sze Chan, Otto C. Boerman, Peter Laverman, Petra Kolenc-Peitl, Marleen Melis and Marion de Jong

    Citation: EJNMMI Research 2014 4:47

    Content type: Original research

    Published on:

  10. Peptide receptor radionuclide therapy (PRRT) is routinely used for advanced or metastasized neuroendocrine tumours (NET). To prevent nephrotoxicity, positively charged amino acids (AA) are co-infused. The aim ...

    Authors: Constantin Lapa, Rudolf A Werner, Christina Bluemel, Katharina Lückerath, Andreas Schirbel, Alexander Strate, Andreas K Buck and Ken Herrmann

    Citation: EJNMMI Research 2014 4:46

    Content type: Original research

    Published on:

  11. Staphylococcus epidermidis (S. epidermidis) has emerged as one of the leading pathogens of biomaterial-related infections. Vascular adhesion protein-1 (VAP-1) is an inflammation-inducible endothelial molecule con...

    Authors: Helena Ahtinen, Julia Kulkova, Laura Lindholm, Erkki Eerola, Antti J Hakanen, Niko Moritz, Mirva Söderström, Tiina Saanijoki, Sirpa Jalkanen, Anne Roivainen and Hannu T Aro

    Citation: EJNMMI Research 2014 4:45

    Content type: Original research

    Published on:

  12. [18F]fluciclatide, a peptide ligand with high affinity for αvβ3/αvβ5 integrins, is a proposed biomarker of tumor angiogenesis. The study rationale was to perform a preliminary evaluation of the relationship betwe...

    Authors: Laura M Kenny, Giampaolo Tomasi, Federico Turkheimer, James Larkin, Martin Gore, Cathryn S Brock, Stephen Mangar and Eric O Aboagye

    Citation: EJNMMI Research 2014 4:30

    Content type: Preliminary research

    Published on:

  13. The α7 nicotinic acetylcholine receptor (nAChR) is an important molecular target in neuropsychiatry and oncology. Development of applicable highly specific radiotracers has been challenging due to comparably l...

    Authors: Sven Rötering, Winnie Deuther-Conrad, Paul Cumming, Cornelius K Donat, Matthias Scheunemann, Steffen Fischer, Guoming Xiong, Jörg Steinbach, Dan Peters, Osama Sabri, Jan Bucerius and Peter Brust

    Citation: EJNMMI Research 2014 4:43

    Content type: Original research

    Published on:

  14. The aim of this pilot study was to evaluate whether the uptake of 89Zr-bevacizumab in non-small cell lung cancer (NSCLC) tumors could be visualized and quantified. The correlation between tumor 89Zr-bevacizumab u...

    Authors: Idris Bahce, Marc C Huisman, Eline E Verwer, Rogier Ooijevaar, Firdaouss Boutkourt, Danielle J Vugts, Guus AMS van Dongen, Ronald Boellaard and Egbert F Smit

    Citation: EJNMMI Research 2014 4:35

    Content type: Original research

    Published on:

  15. The biology of the vulnerable plaque includes increased inflammation and rapid growth of vasa vasorum, processes that are associated with enhanced vascular endothelial growth factor (VEGF)/ imaging receptors f...

    Authors: Yared Tekabe, Maria Kollaros, Adam Zerihoun, Geping Zhang, Marina V Backer, Joseph M Backer and Lynne L Johnson

    Citation: EJNMMI Research 2014 4:41

    Content type: Original research

    Published on:

  16. The trapping mechanisms of the PET hypoxia imaging agent copper(II)-diacetyl-bis(N4-methylthiosemicarbazone) (64Cu(ATSM)) remain unresolved, although its reduction prior to dissociation may be mediated by intrace...

    Authors: Fiona Shaughnessy, Erika Mariotti, Karen P Shaw, Thomas R Eykyn, Philip J Blower, Richard Siow and Richard Southworth

    Citation: EJNMMI Research 2014 4:40

    Content type: Original research

    Published on:

  17. Heterogeneous ventilation in lungs of individuals with allergies, cigarette smokers, asthmatics and chronic obstructive pulmonary disease (COPD) patients has been demonstrated using imaging modalities such as ...

    Authors: Pernilla Norberg, Hans Lennart Persson, Birgitta Schmekel, Gudrun Alm Carlsson, Karl Wahlin, Michael Sandborg and Agnetha Gustafsson

    Citation: EJNMMI Research 2014 4:39

    Content type: Original research

    Published on:

  18. The purpose of the study was to evaluate the applicability of 18 F-labelled amyloid imaging positron emission tomography (PET) agent [ 18 ...

    Authors: Anniina Snellman, Johanna Rokka, Francisco R López-Picón, Olli Eskola, Mario Salmona, Gianluigi Forloni, Mika Scheinin, Olof Solin, Juha O Rinne and Merja Haaparanta-Solin

    Citation: EJNMMI Research 2014 4:37

    Content type: Original research

    Published on:

  19. With the increasing utilization of 68Ge-68Ga radionuclide generators, 68Ga labelled peptides like DOTATATE are receiving more attention in nuclear medicine. On the one hand, the long half-life of the parent nucli...

    Authors: Ferdinand Sudbrock, Thomas Fischer, Beate Zimmermanns, Mehrab Guliyev, Markus Dietlein, Alexander Drzezga and Klaus Schomäcker

    Citation: EJNMMI Research 2014 4:36

    Content type: Original research

    Published on:

  20. Abnormal behaviors of young patients after taking the anti-influenza agent oseltamivir (Tamiflu®, F. Hoffmann-La Roche, Ltd., Basel, Switzerland) have been suspected as neuropsychiatric adverse events (NPAEs)....

    Authors: Chie Seki, Arata Oh-Nishi, Yuji Nagai, Takafumi Minamimoto, Shigeru Obayashi, Makoto Higuchi, Makoto Takei, Kenji Furutsuka, Takehito Ito, Ming-Rong Zhang, Hiroshi Ito, Mototsugu Ito, Sumito Ito, Hiroyuki Kusuhara, Yuichi Sugiyama and Tetsuya Suhara

    Citation: EJNMMI Research 2014 4:24

    Content type: Original research

    Published on:

  21. For yttrium-90 (90Y) radioembolization, the common practice of assuming a standard 1,000-g lung mass for predictive dosimetry is fundamentally incongruent with the modern philosophy of personalized medicine. We r...

    Authors: Yung Hsiang Kao, Butch M Magsombol, Ying Toh, Kiang Hiong Tay, Pierce KH Chow, Anthony SW Goh and David CE Ng

    Citation: EJNMMI Research 2014 4:33

    Content type: Original research

    Published on:

  22. To combine the sensitivity of bioluminescent imaging (BLI) with the 3D and quantitative properties of pinhole single-photon emission computed tomography (SPECT)/micro-computed tomography (CT) (phSPECT/micro-CT...

    Authors: Lode RY Goethals, Tomas J Bos, Luc Baeyens, Frank De Geeter, Nick Devoogdt and Tony Lahoutte

    Citation: EJNMMI Research 2014 4:32

    Content type: Original research

    Published on:

  23. Various diseases derive from pathologically altered β-cells. Their function can be increased, leading to hyperinsulinism, or decreased, resulting in diabetes. Non-invasive imaging of the β-cell-specific glucag...

    Authors: Andreas Jodal, Brigitte Lankat-Buttgereit, Maarten Brom, Roger Schibli and Martin Béhé

    Citation: EJNMMI Research 2014 4:31

    Content type: Original research

    Published on:

  24. Receptor for advanced glycated end product (RAGE) expression is a prominent feature of atherosclerosis. We have previously shown in apoE null mice uptake of a radiolabeled anti-RAGE antibody in atherosclerotic...

    Authors: Lynne L Johnson, Yared Tekabe, Maria Kollaros, George Eng, Ketan Bhatia, Chong Li, Christian G Krueger, Dhanansayan Shanmuganayagam and Ann Marie Schmidt

    Citation: EJNMMI Research 2014 4:26

    Content type: Original research

    Published on:

  25. Cerebral stroke is a severe and frequent condition that requires rapid and reliable diagnosis. If administered shortly after the first symptoms manifest themselves, IV thrombolysis has been shown to increase t...

    Authors: Maria-Joao Ribeiro, Johnny Vercouillie, Severine Debiais, Jean-Philippe Cottier, Isabelle Bonnaud, Vincent Camus, Samuel Banister, Michael Kassiou, Nicolas Arlicot and Denis Guilloteau

    Citation: EJNMMI Research 2014 4:28

    Content type: Original research

    Published on:

  26. ROBO1 is a membrane protein that functions in axon guidance. ROBO1 contributes to tumour metastasis and angiogenesis and may have potential as a target protein of immunotherapy because ROBO1 is specifically ex...

    Authors: Kentaro Fujiwara, Keitaro Koyama, Kosuke Suga, Masako Ikemura, Yasutaka Saito, Akihiro Hino, Hiroko Iwanari, Osamu Kusano-Arai, Kenichi Mitsui, Hiroyuki Kasahara, Masashi Fukayama, Tatsuhiko Kodama, Takao Hamakubo and Toshimitsu Momose

    Citation: EJNMMI Research 2014 4:29

    Content type: Original research

    Published on:

  27. The aim of this study was to investigate the reproducibility of intra- and inter-observer interpretation of [18F]choline positron emission tomography/computed tomography examinations in patients suffering from bi...

    Authors: Clothilde Pegard, Céline Gallazzini-Crépin, Joris Giai, Julien Dubreuil, Cécile Caoduro, Marie-Dominique Desruet, Julie Roux, Alex Calizzano, Daniel Fagret, Chloé Lamesa, Hatem Boulahdour and Jean-Philippe Vuillez

    Citation: EJNMMI Research 2014 4:25

    Content type: Original research

    Published on:

  28. The ability of recombinant antibodies to adequately penetrate into tumours is a key factor in achieving therapeutic effect; however, the behaviour of antibodies at a cellular level in tumours is poorly underst...

    Authors: Marika Ciprotti, Geoffrey Chong, Hui K Gan, Anthony Chan, Carmel Murone, Duncan MacGregor, Fook-Thean Lee, Terrance G Johns, Joan K Heath, Matthias Ernst, Antony W Burgess and Andrew M Scott

    Citation: EJNMMI Research 2014 4:22

    Content type: Original research

    Published on:

  29. Previously, we reported on the unexpected development of distant metastases in the subcutaneous rat pancreas CA20948 tumor model after 4.5 weeks of treatment with RAD001-only or in combination with [177Lu-DOTA0,T...

    Authors: Sander M Bison, Stefan E Pool, Stuart J Koelewijn, Linda M van der Graaf, Harald C Groen, Marleen Melis and Marion de Jong

    Citation: EJNMMI Research 2014 4:21

    Content type: Original research

    Published on:

  30. The utility of 18 F-FDG and 11C-PBR28 to identify aortic wall inflammation associated with abdominal aortic aneurysm (AAA) development was assessed.

    Authors: Sean J English, Jose A Diaz, Xia Shao, David Gordon, Melissa Bevard, Gang Su, Peter K Henke, Virginia E Rogers, Gilbert R Upchurch and Morand Piert

    Citation: EJNMMI Research 2014 4:20

    Content type: Original Research

    Published on:

  31. This study was designed to explore the feasibility of replacing the conventional peri-/intratumoural ultrasound (US)-guided technetium-99m albumin nanocolloid (99mTc-nanocolloid) administration by an injection of...

    Authors: Bas Pouw, Linda J de Wit-van der Veen, Daan Hellingman, Oscar R Brouwer, Marie-Jeanne TFD Vrancken Peeters, Marcel PM Stokkel and Renato A Valdés Olmos

    Citation: EJNMMI Research 2014 4:19

    Content type: Original research

    Published on:

  32. Standard uptake values (SUV) as well as tumor-to-blood standard uptake ratios (SUR) measured with [ 18F-]fluorodeoxyglucose (FDG) PET are time dependent. This poses a serious problem for reliable quantification s...

    Authors: Jörg van den Hoff, Alexandr Lougovski, Georg Schramm, Jens Maus, Liane Oehme, Jan Petr, Bettina Beuthien-Baumann, Jörg Kotzerke and Frank Hofheinz

    Citation: EJNMMI Research 2014 4:18

    Content type: Original research

    Published on:

  33. Vascular endothelial growth factor receptor 2 (VEGFR2) is a crucial mediator of tumour angiogenesis. High expression levels of the receptor have been correlated to poor prognosis in cancer patients. Reliable i...

    Authors: Erik Samén, Li Lu, Jan Mulder, Jan-Olov Thorell, Peter Damberg, Tetyana Tegnebratt, Lars Holmgren, Helene Rundqvist and Sharon Stone-Elander

    Citation: EJNMMI Research 2014 4:17

    Content type: Original research

    Published on:

  34. 123I-CMICE-013 is a novel radiotracer previously reported to have promising characteristics for single-photon emission computed tomography (SPECT) myocardial perfusion imaging. We evaluated the biokinetics and ra...

    Authors: Yin Duan, Julia Lockwood, Lihui Wei, Chad Hunter, Karen Soueidan, Corinne Bensimon, Pasan Fernando, R Glenn Wells and Terrence D Ruddy

    Citation: EJNMMI Research 2014 4:16

    Content type: Original research

    Published on:

  35. Cerenkov luminescence imaging (CLI) is an emerging imaging technique where visible light emitted from injected beta-emitting radionuclides is detected with an optical imaging device. CLI research has mostly be...

    Authors: Jeffrey D Steinberg, Anandhkumar Raju, Prashant Chandrasekharan, Chang-Tong Yang, Karen Khoo, Jean-Pierre Abastado, Edward G Robins and David W Townsend

    Citation: EJNMMI Research 2014 4:15

    Content type: Preliminary research

    Published on:

  36. To date, the majority of protein-based radiopharmaceuticals have been radiolabelled using non-site-specific conjugation methods, with little or no control to ensure retained protein function post-labelling. Th...

    Authors: Adam Badar, Jennifer Williams, Rafael TM de Rosales, Richard Tavaré, Florian Kampmeier, Philip J Blower and Gregory ED Mullen

    Citation: EJNMMI Research 2014 4:14

    Content type: Original research

    Published on:

  37. Sensitive and specific detection of nodal status, sites of metastases and low-volume recurrent disease could greatly improve management of patients with advanced prostate cancer. Prostate-specific membrane ant...

    Authors: Florian Kampmeier, Jennifer D Williams, John Maher, Gregory E Mullen and Philip J Blower

    Citation: EJNMMI Research 2014 4:13

    Content type: Original research

    Published on:

  38. The objective of this study is to investigate the feasibility and the additional interest of a parametric imaging (PI) method to monitor the early tumour metabolic response in a prospective series of oesophage...

    Authors: Pierre Vera, Bernard Dubray, Odré Palie, Irène Buvat, Sébastien Hapdey, Romain Modzelewski, Ahmed Benyoucef, Caroline Rousseau, Marc-Etienne Meyer, Stéphane Bardet, Isabelle Gardin, Frederic Di Fiore and Pierre Michel

    Citation: EJNMMI Research 2014 4:12

    Content type: Original research

    Published on:

  39. Patients with squamous cell carcinoma in the head and neck region (HNSCC) offer a diagnostic challenge due to difficulties to detect small tumours and metastases. Imaging methods available are not sufficient, ...

    Authors: Anna-Karin Haylock, Diana Spiegelberg, Johan Nilvebrant, Karl Sandström and Marika Nestor

    Citation: EJNMMI Research 2014 4:11

    Content type: Original research

    Published on:

  40. 4′-[methyl-11C]-thiothymidine (4DST) is a novel positron emission tomography (PET) tracer to assess proliferation of malignancy. The diagnostic abilities of 4DST and 2-deoxy-2-18 F-fluoro-d-glucose (FDG) for dete...

    Authors: Ryogo Minamimoto, Jun Toyohara, Hideyuki Ito, Ayako Seike, Yoko Miyata, Miyako Morooka, Momoko Okasaki, Kazuhiko Nakajima, Kimiteru Ito, Kiichi Ishiwata and Kazuo Kubota

    Citation: EJNMMI Research 2014 4:10

    Content type: Original research

    Published on:

  41. Neuroendocrine tumors are well vascularized and express specific cell surface markers, such as somatostatin receptors and the glucagon-like peptide-1 receptor (GLP-1R). Using the Rip1Tag2 transgenic mouse mode...

    Authors: Andreas Wicki, Damian Wild, Vincent Prêtre, Rosalba Mansi, Annette Orleth, Jean-Claude Reubi, Christoph Rochlitz, Christoph Mamot, Helmut R Mäcke and Gerhard Christofori

    Citation: EJNMMI Research 2014 4:9

    Content type: Original research

    Published on:

  42. Positron emission tomography (PET) scanning with [18 F]fluorodeoxyglucose (18 F-FDG) is a useful diagnostic and prediction tool in brain tumors, but its value in childhood diffuse intrinsic pontine glioma (DIPG) ...

    Authors: Marc H A Jansen, Reina W Kloet, Dannis G van Vuurden, Sophie EM Veldhuijzen van Zanten, Birgit I Witte, Serge Goldman, W Peter Vandertop, Emile FI Comans, Otto S Hoekstra, Ronald Boellaard and Gert-Jan JL Kaspers

    Citation: EJNMMI Research 2014 4:8

    Content type: Original research

    Published on:

  43. Quantitative measures of 11C-raclopride receptor binding can be used as a correlate of postsynaptic D2 receptor density in the striatum, allowing 11C-raclopride positron emission tomography (PET) to be used for t...

    Authors: Felix P Kuhn, Geoffrey I Warnock, Cyrill Burger, Katharina Ledermann, Chantal Martin-Soelch and Alfred Buck

    Citation: EJNMMI Research 2014 4:7

    Content type: Original research

    Published on:

  44. The purpose of this study was to assess the relationship of CT-perfusion (CTP), 18F-FDG-PET/CT and histological parameters, and the possible added value of CTP to FDG-PET/CT in the initial staging of lung cancer.

    Authors: Martin W Huellner, Timothy D Collen, Philipp Gut, Ralph Winterhalder, Chantal Pauli, Joachim Diebold, Burkhardt Seifert, Klaus Strobel and Patrick Veit-Haibach

    Citation: EJNMMI Research 2014 4:6

    Content type: Original research

    Published on:

  45. In an effort to reduce necessary acquisition time to perform molecular breast imaging (MBI), we compared diagnostic performance of MBI performed with standard 10-min-per-view acquisitions and half-time 5-min-p...

    Authors: Carrie B Hruska, Amy Lynn Conners, Katie N Jones, Amanda L Weinmann, Ravi K Lingineni, Rickey E Carter, Deborah J Rhodes and Michael K O’Connor

    Citation: EJNMMI Research 2014 4:5

    Content type: Original research

    Published on:

  46. Florbetapir is one of several 18F-labeled amyloid plaque imaging tracers for positron emission tomography (PET). As the bio-distribution and radiation dose of PET tracers in human research are important for estim...

    Authors: Abhinay D Joshi, Michael J Pontecorvo, Lee Adler, Michael G Stabin, Daniel M Skovronsky, Alan P Carpenter and Mark A Mintun

    Citation: EJNMMI Research 2014 4:4

    Content type: Preliminary research

    Published on:

  47. We observed a disproportional 18 F-fluorothymidine (F-FLT) uptake in follicular lymphoma (FL) relative to its low cell proliferation. We tested the hypothesis that the ‘excess’ uptake of 18 F-FLT in FL is rela...

    Authors: Marielle J Wondergem, Ken Herrmann, Sergei Syrbu, Josée M Zijlstra, Nikie Hoetjes, Otto S Hoekstra, Saskia AGM Cillessen, Laura M Moesbergen, Andreas K Buck, Julie M Vose and Malik E Juweid

    Citation: EJNMMI Research 2014 4:3

    Content type: Original research

    Published on:

  48. The lupus-associated (La)-specific murine monoclonal antibody DAB4 (APOMAB®) specifically binds dead cancer cells. Using DAB4, we examined La expression in human lung cancer samples to assess its suitability a...

    Authors: Alexander H Staudacher, Fares Al-Ejeh, Cara K Fraser, Jocelyn M Darby, David M Roder, Andrew Ruszkiewicz, Jim Manavis and Michael P Brown

    Citation: EJNMMI Research 2014 4:2

    Content type: Original research

    Published on: